Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
388.50
-3.00 (-0.77%)
At close: Feb 26, 2026
33.51%
Market Cap 21.16B
Revenue (ttm) 2.00B
Net Income (ttm) 716.94M
Shares Out 54.46M
EPS (ttm) 13.15
PE Ratio 29.54
Forward PE n/a
Dividend 11.60 (2.99%)
Ex-Dividend Date Aug 4, 2025
Volume 24,055
Average Volume 8,854
Open 389.00
Previous Close 391.50
Day's Range 387.50 - 390.50
52-Week Range 292.00 - 501.00
Beta -0.16
RSI 43.84
Earnings Date Mar 16, 2026

About Sunmax Biotechnology

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4728
Full Company Profile

Financial Performance

In 2024, Sunmax Biotechnology's revenue was 1.82 billion, an increase of 7.64% compared to the previous year's 1.69 billion. Earnings were 679.41 million, an increase of 8.58%.

Financial Statements

News

There is no news available yet.